Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 9, 2024Siberian Journal of OncologyOpen Access

Genetic engineering in oncology based on CRISPR-Cas9 technology

View Full Paper
Ask AI
Bookmark
Share

Authors

DPD. PolatovaTashkent Pediatric Medical InstituteАMА. Yu. MadaminovMinistry of Health of the Republic of UzbekistanАСАлександр Владимирович СавкинTashkent State University of Law

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Polatova et al. (2024) studied this question.

synapsesocial.com/papers/68e590e9b6db64358752c578https://doi.org/10.21294/1814-4861-2024-23-4-152-161
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Delivering CRISPR: a review of the challenges and approaches2018 · 1,235 citations
  2. 2Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR2020 · 194 citations